Joseph V. Pergolizzi, Christopher G. Gharibo, Jeffrey A. Gudin and Srinivas R. Nalamachu Development of Federally Mandated Risk Evaluation and Mitigation Strategies (REMS) for Transmucosal Immediate-Release Fentanyl Products Pain Practice 13
Article first published online: 6 MAR 2013 | DOI: 10.1111/papr.12040
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.